Association between nociplastic pain and premature endocrine therapy discontinuation in breast cancer patients

Author:

Joyce ElizabethORCID,Carr Grant,Wang Sidi,Brummett Chad M.,Kidwell Kelley M.,Henry N. LynnORCID

Funder

National Cancer Institute

Center for Biomedical Informatics and Information Technology, National Cancer Institute

National Center for Advancing Translational Sciences

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Reference33 articles.

1. Gradishar WJ, Moran MS, Abraham J, Aft R, Agnese D, Allison KH, Anderson B, Burstein HJ, Chew H, Dang C, Elias AD, Giordano SH, Goetz MP, Goldstein LJ, Hurvitz SA, Isakoff SJ, Jankowitz RC, Javid SH, Krishnamurthy J, Leitch M, Lyons J, Mortimer J, Patel SA, Pierce LJ, Rosenberger LH, Rugo HS, Sitapati A, Smith KL, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Ward JH, Wisinski KB, Young JS, Burns J, Kumar R (2022) Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 20:691–722. https://doi.org/10.6004/jnccn.2022.0030

2. Henry NL, Azzouz F, Desta Z, Li L, Nguyen AT, Lemler S, Hayden J, Tarpinian K, Yakim E, Flockhart DA, Stearns V, Hayes DF, Storniolo AM (2012) Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer. J Clin Oncol 30:936–942. https://doi.org/10.1200/jco.2011.38.0261

3. Mortimer JE, Flatt SW, Parker BA, Gold EB, Wasserman L, Natarajan L, Pierce JP, Group WS (2008) Tamoxifen, hot flashes and recurrence in breast cancer. Breast Cancer Res Treat 108:421–426. https://doi.org/10.1007/s10549-007-9612-x

4. Collin LJ, Cronin-Fenton DP, Ahern TP, Goodman M, Mccullough LE, Waller LA, Kjærsgaard A, Damkier P, Christiansen PM, Ejlertsen B, Jensen M-B, Sørensen HT, Lash TL (2021) Early discontinuation of endocrine therapy and recurrence of breast cancer among premenopausal women. Clin Cancer Res 27:1421–1428. https://doi.org/10.1158/1078-0432.ccr-20-3974

5. Gupta A, Henry NL, Loprinzi CL (2020) Management of aromatase inhibitor-induced musculoskeletal symptoms. JCO Oncol Pract 16:733–739. https://doi.org/10.1200/op.20.00113

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3